SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442213
Filing Date
2013-11-14
Accepted
2013-11-14 16:36:19
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d606223d10q.htm 10-Q 665607
2 EX-31.1 d606223dex311.htm EX-31.1 7025
3 EX-31.2 d606223dex312.htm EX-31.2 6747
4 EX-32.1 d606223dex321.htm EX-32.1 7835
  Complete submission text file 0001193125-13-442213.txt   3973777

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20130930.xml EX-101.INS 385330
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20130930.xsd EX-101.SCH 43558
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20130930_cal.xml EX-101.CAL 43981
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20130930_def.xml EX-101.DEF 150887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20130930_lab.xml EX-101.LAB 342880
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20130930_pre.xml EX-101.PRE 240580
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 131220794
SIC: 8731 Services-Commercial Physical & Biological Research